Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021; The Lancet; Vol. 403, iss. 10440

Xehetasun bibliografikoak
Parent link:The Lancet.— .— Amsterdam: Elsevier Science Publishing Company Inc.
Vol. 403, iss. 10440.— 2024.— P. 2133-2161
Beste egile batzuk: Ferrari A. J. Alize, Santomauro D. F. Damian Francesco, Aali A. Amirali, Abate Yo. H. Yohannes Habtegiorgis, Abbafati C. Cristiana, Plotnikov E. V. Evgeny Vladimirovich
Gaia:Title screen
Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic
Текстовый файл
Hizkuntza:ingelesa
Argitaratua: 2024
Gaiak:
Sarrera elektronikoa:https://doi.org/10.1016/S0140-6736(24)00757-8
Formatua: Baliabide elektronikoa Liburu kapitulua
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=678612

MARC

LEADER 00000naa0a2200000 4500
001 678612
005 20250212154434.0
090 |a 678612 
100 |a 20250212d2024 k||y0rusy50 ba 
101 0 |a eng 
102 |a NL 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021  |f Alize J Ferrari, Damian Francesco Santomauro, Amirali Aali [et al.] 
203 |a Текст  |b визуальный  |c электронный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 47 tit 
330 |a Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic 
336 |a Текстовый файл 
461 1 |t The Lancet  |c Amsterdam  |n Elsevier Science Publishing Company Inc. 
463 1 |t Vol. 403, iss. 10440  |v P. 2133-2161  |d 2024 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
701 1 |a Ferrari  |b A. J.  |g Alize 
701 1 |a Santomauro  |b D. F.  |g Damian Francesco 
701 1 |a Aali  |b A.  |g Amirali 
701 1 |a Abate  |b Yo. H.  |g Yohannes Habtegiorgis 
701 1 |a Abbafati  |b C.  |g Cristiana 
701 1 |a Plotnikov  |b E. V.  |c chemist  |c Associate Professor of Tomsk Polytechnic University, Candidate of Chemical Sciences  |f 1983-  |g Evgeny Vladimirovich  |9 16417 
801 0 |a RU  |b 63413507  |c 20250212 
850 |a 63413507 
856 4 |u https://doi.org/10.1016/S0140-6736(24)00757-8  |z https://doi.org/10.1016/S0140-6736(24)00757-8 
942 |c CF